BMY  valuation analysis

Basics
Name: Bristol-Myers Squibb Company
Description: Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. (more)
Industry: Drug Manufacturers-General
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Apr 29, 2021
Market cap: $145.66B (30th)
Sales(TTM): $42.81B (45th)
Earnings(TTM): -$6.20B (833rd)

Value
FFER: 1.22*
Actual price: $64.51
* Earnings were reported May 05, 2021 but we do not have the financials for this quarter. This is likely because the company has not yet released them. However, it might also be a problem with data quality. Regardless, you should take the FFER above with a grain of salt until we get updated financials.

Prices as of EOD 2021-05-12
Price & Estimates
Sales & Earnings history (TTM)
Notable
  • Bristol-Myers Squibb Company's earnings decreased from $979.00M to -$6.20B in the last year.
  • Bristol-Myers Squibb Company's sales grew by 38.1% ($31.01B to $42.81B) over one year against a market average growth of 3.5%.
Earnings / MarketCap
Bristol-Myers Squibb Company
"Drug Manufacturers-General" industry
Sales / MarketCap
Bristol-Myers Squibb Company
"Drug Manufacturers-General" industry
Book / MarketCap
Bristol-Myers Squibb Company
"Drug Manufacturers-General" industry
Equity / Assets
Bristol-Myers Squibb Company
"Drug Manufacturers-General" industry